| Generic/working name | Trastuzumab/docetaxel |
| Company name | Chugai Pharmaceutical Co., Ltd./ Elmed Co., Ltd. (formerly Elmed Eisai Co., Ltd.) |
| Drug type | Monoclonal antibody/cytotoxic agent |
| Drug class | An HER2-specific humanized monoclonal antibody/taxane |
| Dose | Trastuzumab (loading dose of 8 mg/kg and maintenance dose of 6 mg/kg)/ docetaxel (75 mg/m2) |
| Route | iv |
| Schedule of administration | Day1 of a 3-week cycle |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.